Get started
Amgen Inc.Amgen Inc.Amgen Inc.

Amgen Inc.

No trades
See on Supercharts
OverviewFinancialsNewsIdeasDiscussionsTechnicalsForecastSeasonalsBondsETFs

AMGNCL chart


Full chart

AMGNCL upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪143.06 T‬ CLP
Dividend yield (indicated)
3.47%
Price to earnings Ratio (TTM)
20
Basic EPS (TTM)
11,520 CLP
Net income (FY)
‪4.08 T‬ CLP
Revenue (FY)
‪33.17 T‬ CLP
Shares float
‪537.30 M‬
Beta (1Y)
0.37

Employees


Employees (FY)
‪28 K‬
Change (1Y)
‪+1.3 K‬ +4.87%
Revenue / Employee (1Y)
‪1.18 B‬ CLP
Net income / Employee (1Y)
‪145.78 M‬ CLP

About Amgen Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Robert A. Bradway
Website
amgen.com
Headquarters
Thousand Oaks
Founded
1980
ISIN
US0311621009
FIGI
BBG00YFS94W4
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Check out other big names from the same industry as AMGNCL.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

AMGNCL news



Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

AMGNCL highest yielding bonds


AMGN.GA
Amgen Inc. 8.125% 01-APR-2097
Yield to maturity
6.17%
Maturity date
Apr 1, 2097
US31162BP4
Amgen Inc. 5.375% 15-MAY-2043
Yield to maturity
5.99%
Maturity date
May 15, 2043
US31162DU1
Amgen Inc. 5.75% 02-MAR-2063
Yield to maturity
5.76%
Maturity date
Mar 2, 2063
US31162DG2
Amgen Inc. 4.4% 22-FEB-2062
Yield to maturity
5.71%
Maturity date
Feb 22, 2062
US31162DT4
Amgen Inc. 5.65% 02-MAR-2053
Yield to maturity
5.70%
Maturity date
Mar 2, 2053
AMGD
Amgen Inc. 4.2% 22-FEB-2052
Yield to maturity
5.66%
Maturity date
Feb 22, 2052
US31162DK3
Amgen Inc. 4.875% 01-MAR-2053
Yield to maturity
5.63%
Maturity date
Mar 1, 2053
AMGN4436563
Amgen Inc. 4.663% 15-JUN-2051
Yield to maturity
5.59%
Maturity date
Jun 15, 2051
AMGN4437315
Amgen Inc. 4.563% 15-JUN-2048
Yield to maturity
5.58%
Maturity date
Jun 15, 2048
AMGN5186584
Amgen Inc. 2.77% 01-SEP-2053
Yield to maturity
5.53%
Maturity date
Sep 1, 2053
US31162BZ2
Amgen Inc. 4.4% 01-MAY-2045
Yield to maturity
5.51%
Maturity date
May 1, 2045

See all AMGNCL bonds 

Sparks


Curated watchlists where AMGNCL is featured.

See all sparks 

Frequently Asked Questions


The current price of AMGNCL is 293,440 CLP — it hasn't changed in the past 24 hours. Watch Amgen Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BCS exchange Amgen Inc. stocks are traded under the ticker AMGNCL.
We've gathered analysts' opinions on Amgen Inc. future price: according to them, AMGNCL price has a max estimate of 387,559.81 CLP and a min estimate of 172,248.80 CLP. Watch AMGNCL chart and read a more detailed Amgen Inc. stock forecast: see what analysts think of Amgen Inc. and suggest that you do with its stocks.
AMGNCL reached its all-time high on Jul 25, 2024 with the price of 323,490 CLP, and its all-time low was 175,410 CLP and was reached on May 25, 2023. View more price dynamics on AMGNCL chart.
See other stocks reaching their highest and lowest prices.
AMGNCL stock is 7.86% volatile and has beta coefficient of 0.37. Track Amgen Inc. stock price on the chart and check out the list of the most volatile stocks — is Amgen Inc. there?
Today Amgen Inc. has the market capitalization of ‪146.65 T‬, it has increased by 0.17% over the last week.
Yes, you can track Amgen Inc. financials in yearly and quarterly reports right on TradingView.
Amgen Inc. is going to release the next earnings report on Nov 4, 2025. Keep track of upcoming events with our Earnings Calendar.
AMGNCL earnings for the last quarter are ‪5.63 K‬ CLP per share, whereas the estimation was ‪4.94 K‬ CLP resulting in a 13.99% surprise. The estimated earnings for the next quarter are ‪4.87 K‬ CLP per share. See more details about Amgen Inc. earnings.
Amgen Inc. revenue for the last quarter amounts to ‪8.59 T‬ CLP, despite the estimated figure of ‪8.36 T‬ CLP. In the next quarter, revenue is expected to reach ‪8.67 T‬ CLP.
AMGNCL net income for the last quarter is ‪1.34 T‬ CLP, while the quarter before that showed ‪1.65 T‬ CLP of net income which accounts for −18.77% change. Track more Amgen Inc. financial stats to get the full picture.
Yes, AMGNCL dividends are paid quarterly. The last dividend per share was ‪2.29 K‬ CLP. As of today, Dividend Yield (TTM)% is 3.33%. Tracking Amgen Inc. dividends might help you take more informed decisions.
Amgen Inc. dividend yield was 3.45% in 2024, and payout ratio reached 119.05%. The year before the numbers were 2.96% and 68.24% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Oct 1, 2025, the company has ‪28 K‬ employees. See our rating of the largest employees — is Amgen Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Amgen Inc. EBITDA is ‪14.24 T‬ CLP, and current EBITDA margin is 41.84%. See more stats in Amgen Inc. financial statements.
Like other stocks, AMGNCL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Amgen Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Amgen Inc. technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Amgen Inc. stock shows the buy signal. See more of Amgen Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.